Displaying items by tag: Department of Cell, Developmental and Integrative Biology

UAB Heersink School of Medicine has awarded four grants for the 2023/2024 Heersink Multi-Investigator Program Awards, which are each funded with $150,000 per year for two years.
Bradley Yoder, Ph.D., chair of the Department of Cell, Developmental and Integrative Biology, has ranked No. 8 of over 800 principal investigators in the fields of anatomy and cell biology, according to the Blue Ridge Institute for Medical Research report for 2023. Yoder achieved this ranking after securing over $4.2 million in National Institutes of Health (NIH) funding.
In the intricate landscape of cellular biology, a group of dedicated Heersink investigators is unraveling the mysteries of protein glycosylation, particularly focusing on the enigmatic world of sialylation. Led by Susan Bellis, Ph.D., the Glycobiology group at UAB delves deep into the significance of sialic acid modifications and their profound impact on cellular behavior. As we sat down with Bellis, she shared valuable insights into the group's pioneering work and its pivotal role in shaping our understanding of glycobiology.

The UAB Marnix E. Heersink School of Medicine is pleased to announce the newest cohort of James A. Pittman Jr., M.D., Scholars.

Bradley Yoder, Ph.D., professor and chair of the Department of Cell, Developmental and Integrative Biology, introduces the Polycystic Kidney Disease (PKD) Group.

Anupam Agarwal, M.D., dean of the Heersink School of Medicine, welcomed 13 esteemed faculty members, their families, and Heersink School of Medicine leaders to the Wallace Tumor Institute on Nov. 14 to honor the new endowed chairs and professorships for their contributions to modern medicine and medical education.

Braden McFarland, Ph.D., assistant professor in the Department of Cell, Developmental, and Integrative Biology and co-director of the UAB Undergraduate Cancer Biology Program, was recently awarded a $1.6 million R01 grant from the National Cancer Institute of the National Institutes of Health to study the role of human gut microbes in mouse models of glioblastoma.
Page 1 of 7